10.1073/pnas.1218051109 67 KleinS.SheardN
Products are not for human consumption, medical use, or therapeutic application
We queried reports associated with commonly prescribed GLP-1s and identified those coded with dermatologic adverse events
Brand-name FDA-approved GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) remain in a different price category entirely - typically $900 to $1,300+ per month without insurance, with coverage and prior authorization requirements that exclude many patients
Subcutaneous administration achieves brain concentrations twice plasma levels (t 1/2 ~10.5 hr) with no toxicity observed at 15 the therapeutic dose in rats
Die Injektion von Insulin durch gesunde Personen kann zu akuten, lebensbedrohlichen Unterzuckerungen fhren